ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 2604

$514K Total Retail Price of All Prescriptions

Rank: 197 out of 2604

316 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 316 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 519 514 1 4
SIMVASTATIN 474 444 2 2
FUROSEMIDE 455 444 3 8
METOPROLOL SUCCINATE 347 347 4 17
LISINOPRIL 343 342 5 3
WARFARIN SODIUM 341 321 6 13
OMEPRAZOLE 340 323 7 5
AMLODIPINE BESYLATE 321 309 8 6
HYDROCODONE-ACETAMINOPHEN 252 232 S3 9 1
POTASSIUM CHLORIDE 240 224 10 16
HYDROCHLOROTHIAZIDE 184 179 11 10
PRAVASTATIN SODIUM 159 136 12 14
METOPROLOL TARTRATE 152 140 13 9
ATORVASTATIN CALCIUM 141 138 14 19
RANITIDINE HCL 136 125 15 25
METFORMIN HCL 130 128 16 7
PREDNISONE 123 116 17 34
DIGOXIN 115 107 18 71
DONEPEZIL HCL 114 114 19 28
ISOSORBIDE MONONITRATE ER 107 107 20 38
ALLOPURINOL 90 90 21 35
BYSTOLIC 88 86 22 165
LANTUS 81 69 23 40
NAMENDA 79 79 24 37
GABAPENTIN 78 78 25 12
TAMSULOSIN HCL 76 76 26 30
CLOPIDOGREL 75 75 27 39
NEXIUM 75 75 27 53
CARVEDILOL 73 73 29 26
MELOXICAM 71 59 30 36
CITALOPRAM HBR 66 66 31 18
LOVASTATIN 65 54 32 24
DIOVAN 64 64 33 123
MIRTAZAPINE 64 64 33 52
ATENOLOL 64 64 33 11
GLIMEPIRIDE 64 64 33 57
LOSARTAN POTASSIUM 64 62 33 20
RISPERIDONE 63 57 38 65
METFORMIN HCL ER 59 51 39 72
LANTUS SOLOSTAR 57 49 40 84
FENTANYL 57 57 S2 40 48
ADVAIR DISKUS 55 50 42 41
SPIRIVA 54 54 43 45
GALANTAMINE HBR 54 54 43 276
PLAVIX 53 53 45 75
TERAZOSIN HCL 53 53 45 129
CIPROFLOXACIN HCL 52 51 47 59
SERTRALINE HCL 51 47 48 23
ESCITALOPRAM OXALATE 50 39 49 73
ENALAPRIL MALEATE 50 46 49 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.